SkinBioTherapeutics Banner Image


  • Ticker SBTX
    Exchange LSE More
  • Industry Biotechnology More
  • Sector Healthcare More
SkinBioTherapeutics Logo Image
  • 1-10 Employees
  • Based in Macclesfield, England
SkinBioTherapeutics is a life science company focused on skin health. The Company’s proprietary platform technology, SkinBiotix®, is based upon discoveries made by CEO Dr. Catherine O’Neill and Professor Andrew McBain at The University of Manchester. The SkinBioTherapeutics’ platform applies research discoveries made on the activities of lysates derived from probiotic bacteria when appliedMore to skin. The Company has shown that the SkinBiotix® platform can improve the barrier effect of skin models, improve repair and reduce bacterial load.
4.8 / 5.0 (73)

SkinBioTherapeutics reports have an aggregate usefulness score of 4.8 based on 73 reviews.


Most Recent Annual Report

MOST RECENT 2022 Annual Report

Older/Archived Annual Reports

SkinBioTherapeutics Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!